1 row is stored for this page
| Field | Field type | Value |
|---|
| generic | String | Promethazine (hydrochloride) |
| brand | String | Phenergan, Promethegan (suppositories) |
| structure | File | |
| classes | List of String, delimiter: , | [[:Category:Antihistamines|First-generation antihistamine]] • [[:Category:Phenothiazines|Phenothiazine]] • [[:Category:Antiemetics|Antiemetic]] |
| mechanism | String | |
| uses | String | '"`UNIQ--vote-0000001D-QINU`"', '"`UNIQ--vote-0000001E-QINU`"', '"`UNIQ--vote-0000001F-QINU`"', '"`UNIQ--vote-00000020-QINU`"', '"`UNIQ--vote-00000021-QINU`"' |
| starting_dose | String | Allergy: 25 mg PO BID-QID. Nausea/vomiting: 12.5-25 mg PO/IM/IV/PR every 4-6 hours. Motion sickness: 25 mg PO 30-60 minutes before travel. '''Pediatric <2 years: contraindicated''' |
| preparations | String | Tablets 12.5, 25, 50 mg; oral syrup 6.25 mg/5 mL; suppositories 12.5, 25, 50 mg; injection 25 mg/mL and 50 mg/mL |
| fda_max | String | 100 mg/day (adult) |
| pill_id | Text | |
| routes | List of String, delimiter: , | Oral • IM • IV (with caution) • rectal |
| onset | String | 20 minutes (oral); 5 minutes (IV) |
| duration | String | 4-6 hours |
| halflife | String | 12-15 hours'"`UNIQ--ref-00000022-QINU`"' |
| bioavailability | String | ~25% (oral, with extensive first-pass)'"`UNIQ--ref-00000023-QINU`"' |
| pregnancy | String | Older agent with substantial use experience, including in hyperemesis gravidarum; broadly reassuring observational data'"`UNIQ--ref-00000024-QINU`"' |
| legal | String | |
